FDA Investigator Andrew B Slarve
Andrew B Slarve has inspections in 1 countries as of 22 Sep 2023. Andrew B Slarve has collaborated with a combined 1922 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
41
Last Inspection Date:
22 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adam S Freeman,
Alex G Kalugin,
Alexis R Ajello,
Alice A Blair,
Alla Dubrovsky,
Andrew E Kay,
Andrew T Todd,
Andrew Tadros,
Angel K Sandhu,
Annie H Lam,
Bak,
Baker,
Blair,
Bradley J Maunder,
Breena L D'ambrogi,
Bruce D Broidy,
Camacho,
Capri R Woolridge,
Carl Lee,
Carr,
Celeste K Wong,
Chan,
Chloe Anne K Le,
Chloe Anne Leong,
Christine M Parmentier,
Cindy W Lewis,
Courtney R Bolton,
Cynthia L Ford,
Damon A Growl,
Daniel C Geffin,
Daniel Velasquez,
Darla R Bracy,
David A Laplante,
David A Lum,
David G Eng,
Davina M Martinez,
Deborah K Richardson,
Denise Connelly,
Dustin R Abaonza,
Edna J Hidalgo,
Elaine S Chow,
Elizabeth P Mayer,
Elodie Xtong Lin,
Eric J Heinze,
Erica R Pomeroy,
Estefania Fernandez,
Foley,
Frank P Bianco,
Gillenwater,
Gina M Hall,
Henry K Lau,
Huy T Pham,
Italia Nappi,
James C Lee, PharmD,
James C Yee,
Jane G Choi,
Janice Wai,
Jeanne A Young,
Jeffrey W Shrifter, DPM,
Jennifer L Johnson,
Jennifer S King,
Joan T Briones,
Jocelyn T Ramos,
John A Liu,
Jolene S Hedgecock,
Joseph Tibay,
Juan A Morales,
Jude C Dikes,
Kacie M Crowther,
Karen D Phung,
Karla J Gibler,
Kavita K Lalwani,
Kimberly L Anderson,
Kristin M Abaonza,
Lance M De Souza, MBA,
Larkin R Buckalew,
LCDR Jennifer H Rhyu,
Lealand Lee,
Leongc,
Lija V Fellows,
Linda Linh T Nguyen,
Linda S Shook,
Lorraine M Humes,
Lorraine N Williams,
LT Mark A Chen, MPH,
Lydia S Chan,
Mabel M Lee,
Macropolk,
Marissa J Chan,
Mark I Nakano,
Matthew K Wong,
Mcgrewp,
Megan E Kulas,
Melody M Ragasa Leong,
Michael L Myers,
Monique C Lo,
Nicole Yuen,
Nympha V Florendo,
Peter E Baker,
Phung,
Quynh H Strandberg,
Randall J Plunkett,
Raymond Souweha,
Ronald P Boyce,
Rumany C Penn, PharmD,
Sandra S Saniga,
Sean P Desbrow,
Sergio Chavez (NMI),
Sondra R Davis,
State Agency,
Steve P Yost,
Steven B Chiu,
Steven J Branch,
Terrence Gee,
Thomas N Adjabeng,
Timothy C Grome,
Vi T Au,
Watsondavina,
Wayne L Jefferson,
Wen Jun Peng,
William J Weis,
Yen Tso Kuo
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more